Showing posts with label IV Drip. Show all posts
Showing posts with label IV Drip. Show all posts

Aug 31, 2011

Insulin Drug tips.....



Insulins are used to manage diabetes mellitus, a chronic illness that results from an absolute or relative deficiency of insulin. There are various types of insulins available to help manage diabetes. For each type of insulin, you will need to know the onset, peak, and duration. NCLEX questions may focus on when clients need to be assessed after insulin administration. Assessment should occur frequently, but especially during the PEAK of insulin action, as this is when hypoglycemia is most likely to occur. Signs and symptoms of abrupt-onset hypoglycemia include tachycardia, palpations, diaphoresis, and shakiness. Gradual onset hypoglycemia may manifest with headache, tremors, or weakness.

We’ll CLIMB TO THE PEAK…starting FAST and ending SLOW.

FASTEST: Rapid acting insulins: Lispro (Humalog). 
  • ONSET: Less than 15 minutes
  • PEAK: 30 minutes to 1 hour
  • DURATION: 3 to 4 hours
FAST: Short acting insulins: Regular (Humulin R).
  • ONSET: 30 minutes to 1 hour
  • PEAK: 2 to 3 hours
  • DURATION: 5 to 7 hours
SLOW: Intermediate-acting insulins: NPH insulin (Humulin N).
  • ONSET: 1 to 2 hours
  • PEAK: 4 to 12 hours
  • DURATION: 18 to 24 hours
SLOWEST: Long-acting insulins: Insulin glargine (Lantus).
  • ONSET: 1 hour
  • PEAK: None
  • DURATION: 10.4 to 24 hours
Many students look for ways to more easily remember all of the ranges associated with insulin. It is helpful to think generally rather than trying to recall all exact numbers when memorizing this information. Also, if you can only remember one thing about each type of insulin remember, CLIMB TO THE PEAK.

Pick one number from each timeframe (onset, peak, duration) to help reduce the values that you’re trying to memorize. Remember that onset, peak, and duration build sequentially as you move from one type of insulin to another, so it may be helpful to remember, for example, that onset times go from 15 minutes, to 30 minutes, to 1 hour (trend: all onsets are less than an hour). Peak times go from 30 minutes, to 2 hours, to 4 hours (trend: even numbers). Finally, duration goes from 3 hours, to 5 hours, to 24 hours.

If you always organize your thoughts by O.P.D. (onset, peak, and duration), starting FAST (rapid acting) and ending SLOW (long acting) when studying the different types of insulin, these tips will be helpful. The key is consistency…looking at values in the same order every time.

Jun 9, 2011

The right plasma volume expander....

Daniel O'Neill, BSc, RN, is a staff nurse, A&E, John Radcliffe Hospital, Oxford
Plasma volume expanders are used for the treatment of circulatory shock. They restore vascular volume, stabilising circulatory haemodynamics and maintaining tissue perfusion. Two general categories of expander are used: crystalloids or colloids, or a mixture of both (Baskett, 1994; Astiz and Rackow, 1999).

Plasma volume expanders are used for the treatment of circulatory shock. They restore vascular volume, stabilising circulatory haemodynamics and maintaining tissue perfusion. Two general categories of expander are used: crystalloids or colloids, or a mixture of both (Baskett, 1994; Astiz and Rackow, 1999).

The crystalloids most commonly used are normal saline (0.9% NaCl) or lactated Ringer's solution. Colloids include Haemaccel, Gelofusin and the naturally occurring plasma substances (albumin, plasma protein fraction). Debate on the preferred type of volume expander is ongoing (Holt and Dolan, 2000).

Albumin is normally present in the blood and constitutes 50-60% of the plasma proteins and 80-85% of the oncotic pressure. Plasma protein fraction consists of 88% albumin and 12% globulins. Plasma protein fraction is effective in maintaining blood volume but does not increase oncotic pressure.

How do plasma volume expanders work?
Plasma volume expanders increase the oncotic pressure in the intravascular space. Water moves from the interstitial spaces into the intravascular space, increasing the circulating blood volume. This increased volume leads to an increase in central venous pressure, cardiac output, stroke volume, blood pressure, urinary output and capillary perfusion, and a decrease in heart rate, peripheral resistance and blood viscosity.

Key functions
The administration of a volume of 25% albumin solution causes three-and-a-half times the administered volume to be drawn into the circulation within 15 minutes. A single infusion of dextran 40 increases the circulating blood volume to a maximum within a few minutes but the effect tails off as it breaks down more rapidly than dextran 70 or 75, which reaches maximum volume within an hour but maintains this for longer. Hetastarch (etherified starch) produces a volume expansion that is slightly greater than the amount administered, with maximum expansion occurring within minutes. With all these products, volume expansion lasts about 24 hours.

Dextran 40, unlike the higher molecular weight dextran products, also improves microcirculation independently of its volume-expanding effects. The exact mechanism of this activity is unknown, but it is believed to occur by minimising erythrocyte aggregation and/or decreasing blood viscosity.

Dextran is used clinically in the prophylaxis of venous thrombosis and pulmonary embolism in patients undergoing surgery that carries a high risk of thromboembolic complications.

The main features of crystalloids are that they have an intravascular half-life of between 30 and 60 minutes and must be given in amounts equal to three times the volume lost. Colloids such as Haemaccel last several hours and replace the volume of blood lost in a ratio of one to one.

Which plasma volume expander is best?
Some clinicians have strong opinions on the pros and cons of using a crystalloid versus a colloid plasma expander. A study of 26 A&E patients with hypovolaemia and septic shock compared the haemodynamic and respiratory effects of normal saline (NS), albumin and hetastarch (Rackow et al, 1983). Patients were given enough plasma expander to reach a target central venous pressure.

About two to four times greater fluid volume was needed when using NS compared with albumin and hetastarch. The only haemodynamic differences included a greater increase in cardiac output in the albumin and hetastarch groups compared with the NS group.

Colloid osmotic pressure decreased below baseline in the NS group, which is interesting as it could cause serious problems, especially if either function is impaired, resulting in a higher incidence of pulmonary oedema in the NS group compared with the other groups.

Both albumin and hetastarch groups maintained or increased the colloid osmotic pressure compared with the baseline. In general there were no significant differences between the albumin and hetastarch groups.

Potential complications
Nurses overseeing an infusion of plasma expanders must be aware of the possible complications. Anaphylaxis reactions can occur with hetastarch, albumin or any of the dextran preparations. Dextran is produced by a bacterium, Leuconostoc mesenteroides, which contributes to its antigenicity. However, improved preparation methods have resulted in the incidence of hypersensitivity reactions falling. Of the dextran products, dextran 40 has less potential to cause an adverse reaction. The risk of antigenicity is lower with hetastarch than with dextran. With albumin, anaphylactic reactions are more likely to occur with high doses or repeat administration than with low doses.

With any product, the patient should be closely observed during the first few minutes of administration. Allergic reactions include urticaria, nasal congestion, wheezing, tightness of the chest, nausea and vomiting, periorbital oedema and hypotension, which can be mild or severe. Volume expander therapy should be stopped at the first sign of an allergic reaction.

Substances with a molecular weight of 50,000 daltons or less can be filtered by the glomerulus, so dextran 40 could cause renal injury if tubular flow is decreased. Dextran 40 undergoes rapid urinary excretion, increasing the viscosity and specific gravity of urine. Patients with a reduced flow of urine are particularly susceptible to tubular stasis and blocking, so it is essential to maintain hydration. Renal failure does not occur with dextran 70 or 75, but input and output must be monitored as volume overload may lead to cardiovascular effects, as can fluid overload with a crystalloid.

Excessive administration of albumin, dextran or hetastarch can precipitate cardiac failure, pulmonary oedema and peripheral oedema of the lower extremities, hypertension or tachycardia. Concentrations in plasma protein fraction may cause a higher incidence of hypotension. Nurses need to monitor patients' haemodynamic state.

In acutely ill patients measurements other than central venous pressure, such as cardiac output studies, may need to be carried out. Fluid balance may need to be sustained in conjunction with inotropic/cardiosupportive drug therapy.

Bleeding is a serious concern with hetastarch therapy. Hetastarch appears to affect total platelet count and haemodilution can exacerbate this. A prolonged bleeding time, partial thromboplastin time and prothrombin time can result as a temporary adverse effect. However, at volumes less than 1,500ml, effects on coagulation are minor.

Conclusion

To be able to administer intravenous therapies, the nurse must have a thorough knowledge of the principles and their applications. Intravenous medications should never be given without full knowledge of immediate and late effects, toxicity and nursing implications (UKCC, 1992). Only by continually updating and reviewing practice can the nurse develop as a safe practitioner.

Jun 8, 2011

Choosing the right fluid to counter hypovolemic shock........


A PATIENT THREATENED
by hypovolemic shock needs immediate intravenous (I.V.) fluid resuscitation to survive. Do you know which fluids are appropriate-and which to avoid? In this article, we'll examine the fluids used for resuscitation and discuss which one is right for your patient, depending on his condition. Let's start by looking at how fluid loss or shifts within the body lead to hypovolemia.

What causes hypovolemia?


The body has two main fluid compartments: Fluid in the cells is called intracellular fluid; fluid in plasma (intravascular) and interstitial space is called extracellular fluid.


In a healthy person, the amount of fluid in intracellular and extracellular spaces is relatively constant, but water and solutes, such as electrolytes, move among the compartments to maintain homeostasis. Fluid intake and output provide a rough measure of homeostasis: They must be approximately equal to maintain balance. Illness or injury upsets the balance, requiring your intervention.

Hypovolemia
results from internal fluid shifts or external fluid losses:

* Internal fluid shifts leading to hypovolemia occur as fluid moves out of the intravascular compartment into another area of the body, such as the interstitial space; for example, during internal hemorrhage associated with a hemothorax, long-bone fracture, or ruptured spleen. Third-spacing occurs when fluid accumulates in the extracellular and intracellular spaces and in a third body space (such as the intestinal lumen) that doesn't support circulation.

* External fluid loss can result from bleeding, vomiting, diarrhea, nasogastric suction, diuretic therapy, diabetes insipidus, hyperglycemic osmotic diuresis, severe burns, trauma, and surgery.

The goal of fluid resuscitation
is to maintain perfusion to the patient's vital organs, especially the brain and heart, by restoring circulating volume.

Warning signs of shock

Untreated hypovolemia can quickly evolve into hypovolemic shock, which produces characteristic signs and symptoms depending on severity:

* mild hypovolemic shock-diaphoresis, anxiety, increased capillary refill time, and cool extremities

* moderate hypovolemic shock-the same as for mild shock, plus increased heart and respiratory rates and decreased urine output

* severe hypovolemic shock-the same as for moderate shock, plus hemodynamic instability, hypotension, and altered mental status, including coma.

Regular assessments can help you identify and treat hypovolemia at an early stage, before the patient's condition deteriorates. Remember that very young and elderly patients are especially vulnerable to fluid imbalances.

Choosing the right fluid


Parenteral fluids can be classified in several ways; for example, crystalloid or colloid, blood and blood products, and pharmaceutical plasma expanders. Two main factors affect the choice of fluid for your patient: how the volume loss occurred and which solutes need to be replaced.

First, address the underlying problem; for example, stop the bleeding or treat the vomiting or diarrhea. Next, provide I.V. fluids to restore circulating blood volume. Let's look at how I.V. fluids are categorized and when each type is indicated.

Crystalloids


Crystalloid solutions closely mimic the body's extracellular fluid. Common examples are 0.9% sodium chloride solution and Ringer's solution. Given I.V., crystalloid solutions diffuse through the capillary walls that separate plasma from interstitial fluid. They can be used to expand both intravascular and extravascular fluid volume.

Crystalloids are further classified by tonicity, or the number of particles (or solutes) in the solution. A fluid's tonicity controls fluid movement between fluid compartments. To maintain homeostasis, fluids move from areas of lower solute concentration to areas of higher solute concentration, a process called osmosis.

Isotonic fluids have the same tonicity as plasma. They're useful in raising intravascular volume without altering fluid shifts in or out of cells or changing plasma electrolyte concentration. Common isotonic fluids include 0.9% sodium chloride solution, D^sub 5^W, Ringer's solution, and lactated Ringer's solution.

Use isotonic fluids for patients whose fluid losses stem from vomiting and diarrhea, those awaiting an infusion of blood and blood products, and patients who lost fluid during surgery. Because isotonic fluids expand circulating volume, monitor for fluid excess or overload.

Hypotonic fluids, such as 0.45% sodium chloride solution, help the body restore homeostasis by moving fluid into the intracellular compartment. Because hypotonic fluids have a lower concentration of particles than plasma, they exert less osmotic pressure than the fluid in the extracellular compartment. Hypotonic fluids often are given to patients whose sodium intake must be restricted, such as those with hypernatremia.

Monitor the patient closely; too much of a hypotonic fluid can cause intravascular fluid depletion, hypotension, and cellular edema and tissue damage.

Hypertonic fluids have a greater tonicity than fluid in the extracellular compartment, so they exert more osmotic pressure. These solutions draw fluid from the intracellular to the extracellular compartment, causing cells to shrink and relieving cellular edema. But hypertonic solutions (such as 3% or 5% sodium chloride solution) raise the risk of volume overload, especially in a patient with heart failure, so assess his response to treatment frequently.

Another hypertonic solution, concentrated dextrose in water (20%, 40%, 50%, 60%, or 70%) is often added to amino acid solutions administered via central vascular access devices to correct hypoglycemia and provide calories. Monitor the patient's blood glucose levels for hyperglycemia and urine output and urine specific gravity for osmotic diuresis. Also monitor the patient's serum electrolytes.

Colloids


Colloids contain undissolved particles, such as protein, sugar, and starch molecules, which are too big to pass through capillary walls. A colloid solution draws fluid from the interstitial and intracellular spaces, increasing intravascular volume. The degree of osmotic pull that a colloid exerts depends on its particle concentration.

Colloid solutions have the same effect as hypertonic solutions and are given in smaller volumes. They also have a longer duration of action because the larger molecules stay in the intravascular compartment longer.

Albumin is the most frequently used colloid solution. A commercially prepared solution, albumin is extracted from human plasma and heated to kill pathogens. It's available in 5% or 25% concentrations (the 5% solution is isotonic) and contains no clotting components. Use albumin for volume expansion when crystalloid solutions are inadequate, as a plasma substitute when treating patients with hypovolemic shock and massive hemorrhage, and to treat patients exhibiting third-spacing of fluid into the interstitial spaces.

A patient who's lost fluid during thoracic surgery would benefit from albumin used as the primary fluid in resuscitation because it enhances blood volume, improves hemodynamics, and reduces the need for blood transfusions.

Blood and blood products

Whole blood contains red blood cells (RBCs), white blood cells, platelets, and plasma. Because storage degrades blood quality fairly quickly, units of whole blood are typically broken down into separate units of RBCs, platelets, and fresh frozen plasma. White blood cells may be removed from the plasma during processing of the blood product. Blood loss can often be managed with blood components and crystalloid and colloid solutions. Whole blood is rarely used unless it's less than 24 hours old and the patient is exsanguinating.

Packed RBCs have the same cell mass as whole blood, making them a good choice for patients who need increased RBC mass and oxygen-carrying capacity without volume overload or for patients with symptomatic anemia, hypovolemic shock, or symptomatic acute or chronic blood loss. Each unit of packed RBCs is typically infused over 1 to 2 hours, but always within 4 hours. Monitor a patient with a poor ejection fraction or a history of heart failure closely. He may require infusions of packed RBCs (smaller-volume infusions than whole blood), perhaps alternating with doses of a diuretic.

Fresh frozen plasma contains albumin, globulins, antibodies, and all other plasma proteins and clotting factors. Although it shouldn't be used for volume expansion, it's useful when clotting factors are required; for example, to counteract the effects of warfarin therapy.

Pharmaceutical plasma expanders

These colloid fluids include hetastarch (Hespan), a synthetic polymer with volume-expanding traits similar to 5% albumin, but with longer-lasting effects. Hetastarch is useful for patients with intravascular volume loss related to trauma, burns, hemorrhage, or surgery.


Dextran is available in low molecular weight (dextran 10%) or high molecular weight (dextran 6%). Composed of large glucose polymers that draw water into the intravascular space, dextran exerts its maximum effect about 1 hour after administration; however, effects may last 24 hours.

Mannitol is a sugar alcohol substance dissolved in 0.9% sodium chloride solution. Available in concentrations from 5% to 25%, mannitol contains an inactive sugar that remains in the vascular space to pull water from the interstitial and intracellular spaces, increasing plasma volume and producing an osmotic diuresis. Mannitol's primary uses are to decrease intracranial pressure from cerebral edema, reverse cerebrospinal fluid buildup, and lower intraocular pressure. Mannitol is sometimes also used for patients in hypoperfused states; for example, a postoperative patient who's had renal artery clamping during abdominal aortic aneurysm repair. During this procedure, perfusion to the kidneys is poor or absent for 15 to 20 minutes. When the clamp is released, mannitol is given to increase intravascular volume and produce osmotic diuresis, improving glomerular filtration and increasing urine flow.

Monitoring for complications

Consider any patient needing fluid resuscitation to be hemodynamically unstable and monitor him closely for complications. Besides keeping meticulous intake and output measurements, record daily weights, lab values, base deficit, serum lactate levels, and vital signs trends. Keep an eye on your patient's skin integrity, as fluid loss or displacement puts him at risk for skin breakdown.

Even a successful fluid resuscitation carries certain risks. For example, aggressive administration of crystalloid solutions can lead to volume overload, electrolyte disturbances, coagulopathy heart failure, pulmonary edema, interstitial edema, and acute respiratory distress syndrome. Colloids and blood products can trigger allergic reactions, including anaphylactic shock. During any fluid resuscitation involving blood components, implement safety measures to assess for and prevent transfusion reactions; be ready to intervene quickly if a reaction occurs.

Massive infusions of cool or room temperature solutions can cause hypothermia. Warm resuscitation fluids according to the manufacturer's guidelines and your facility's policies and procedures to prevent hypothermia.

Diving in

By watching for signs of hypovolemic shock, identifying the source of your patient's fluid loss, and choosing the right replacement, you can correct your patient's fluid imbalance and restore homeostasis.

SELECTED REFERENCES

Corrigan, A., ed: Core Curriculum for Intravenous Nursing, 2nd edition. Philadelphia, Pa., Lippincott Williams & Wilkins, 2000.

Gahart, B., and Nazareno, A.: Intravenous Medications 2003, 20th edition. St. Louis, Mo., Mosby, Inc., 2003.

Kruse, J., et al., eds: Saunders Manual of Critical Care, 1st edition. Philadelphia, Pa., W.B. Saunders Co., 2002.

McKenry, L., et al.: Mosby's Pharmacology in Nursing, 21st edition. St. Louis, Mo., Mosby, Inc., 2001.

BY LOUISE DIEHL-OPLINGER, RN, APRN,BC, CCRN, MSN, AND MARY FRAN KAMINSKI, RN, CCRN

Louise Diehl-Oplinger is an advanced practice nurse at Popkave-Mascarenhas Cardiology in Phillipsburg, N.J. Mary Fran Kaminski is clinical educator in the critical care division at Sacred Heart Hospital in Allentown, Pa.

May 13, 2011

What exactly is Phlebitis.....


Nurses know that phlebitis is the inflammation of the vein and is considered an adverse patient outcome. Vascular access sites should be routinely assessed for signs and symptoms of phlebitis , as well as the severity of phlebitis. According to the Infusion Nurses Society(INS) Standards of Practice, a standardized scale that is valid, reliable, and clinically feasible should be used.  For the adult population, two phlebitis scale have demonstrated validity and reliability.
One of the two scales is the phlebitis scale from the Infusion Nurses Society that many infusion nurses have used for years.
Phlebitis Scale (from the Infusion Nursing Standards of Practice 2011 S47)
Grade 0 – No symptoms
Grade 1 – Erythema at access site with or without pain
Grade 2 – Pain at access site with erythema and/or edema
Grade 3 – Pain at access site with erythema and/or edema, streak formation, palpable venous cord.
Grade 4 – Pain at access site with erythema and/or edema, streak formation, palpable venous cord greater than 1 in in length; purulent drainage.
The other is the Visual Infusion Phlebitis (VIP) scale, developed by Andrew Jackson, Consultant Nurse Intravenous Therapy and Care, Rotherham General Hospitals, NHS Trust. This scale was evaluated in a study by Gallant and Schultz.  (Gallant P and Schultz AA (2006) Evaluation of a visual infusion phlebitis scale for determining appropriate discontinuation of peripheral intravenous catheters. Journal of Infusion Nursing. vol. 29, no. 6, p. 338-45.)




Phlebitis resulting from peripheral IV’s should be monitored and the incidence should be calculated. A consistent,  standard, and clinically feasible calculation based on point prevalence should be use to monitor phlebitis rate.
So next time you find yourselves looking at an arm with possible phlebitis,  use a phlebitis scale to assess and document the severity of your findings! No guessing required….

For more information or to purchase the 2011 Infusion Nursing Standards of Practice, click here. 

**click on the Title link above to be re-directed to the originating Blog

 


Mar 31, 2011

Fluid and Electrolytes....

0.9% NaCl (normal saline) ---------------------------- Isotonic
0.25% NaCl ----------------------------------------- Hypotonic
0.45% NaCl ----------------------------------------- Hypotonic
2.5% dextrose --------------------------------------- Hypotonic
Lactated Ringer's solution --------------------------- Isotonic
D5W (acts as a hypotonic solution in body) ----------- Isotonic
D5 NaCl --------------------------------------------- Hypertonic
D5 in Lactated Ringer's ------------------------------ Hypertonic
D5 0.45% NaCl -------------------------------------- Hypertonic